The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Tuesday, March 11, 2008 - 10:45 AM
A7d

Use of VSD to Monitor HPV-related Outcomes and HPV Types

Eileen F. Dunne, The Division of Sexually Transmitted Disease Prevention/Epidemiology and Surveillance Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E-02, Atlanta, GA, USA

The Vaccine Safety Datalink (VSD) is an ongoing monitoring project in which CDC collects data on vaccine safety in the United States; 3 VSD sites will add HPV-related outcomes (CIN, genital warts, vaginal and vulvar lesions, and RRP) to their assessments. This data will provide valuable information on impact of the HPV vaccine. Specimens collected in 2 VSD sites will assist in monitoring distribution of HPV types in cytology and biopsy specimens after introduction of the HPV vaccine.

See more of Monitoring the Impact of the Human Papillomavirus (HPV) Vaccine: The National Perspective
See more of Symposium

See more of The 2008 National STD Prevention Conference